Understanding Variability in Posaconazole Exposure Using an Integrated Population Pharmacokinetic Analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding Variability in Posaconazole Exposure Using an Integrated Population Pharmacokinetic Analysis
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 11, Pages 6879-6885
Publisher
American Society for Microbiology
Online
2014-09-09
DOI
10.1128/aac.03777-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing
- (2014) M. J. Dolton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis
- (2013) Seyedmojtaba Seyedmousavi et al. Expert Review of Anti-Infective Therapy
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of Different Dosing Strategies of Oral Posaconazole in Patients with Compromised Gastrointestinal Function and Who Are at High Risk for Invasive Fungal Infection
- (2012) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasma Concentrations of Posaconazole Administered via Nasogastric Tube in Patients in a Surgical Intensive Care Unit
- (2012) Dominic Störzinger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
- (2012) J. J. Vehreschild et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies
- (2012) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Implementation of dose superimposition to introduce multiple doses for a mathematical absorption model (transit compartment model)
- (2012) Jun Shen et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Posaconazole Treatment in Hematology Patients
- (2012) Marie-Rose B. S. Crombag et al. THERAPEUTIC DRUG MONITORING
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
- (2011) Martin Bergstrand et al. AAPS Journal
- Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
- (2011) Jeroen Walravens et al. CLINICAL PHARMACOKINETICS
- Lack of Evidence for Exposure–Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections
- (2011) O A Cornely et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake
- (2011) C. Eiden et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis
- (2011) Alexander M. Bryant et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Posaconazole Plasma Concentrations in Critically Ill Patients
- (2011) John Ray et al. THERAPEUTIC DRUG MONITORING
- Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview
- (2010) Hans-Peter Lipp BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Rifampin and Posaconazole Coadministration Leads to Decreased Serum Posaconazole Concentrations
- (2010) Carina Hohmann et al. CLINICAL INFECTIOUS DISEASES
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers
- (2010) R. J. M. Bruggemann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effect of Varying Amounts of a Liquid Nutritional Supplement on the Pharmacokinetics of Posaconazole in Healthy Volunteers
- (2009) G. Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers
- (2009) E. S. Dodds Ashley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Factors Influencing Pharmacokinetics of Prophylactic Posaconazole in Patients Undergoing Allogeneic Stem Cell Transplantation
- (2009) V. Kohl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
- (2009) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene
- (2009) E. Mavridou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
- (2009) D. Lebeaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
- (2009) Roger J. M. Brüggemann et al. CLINICAL INFECTIOUS DISEASES
- Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome
- (2009) M.A. AbuTarif et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
- (2008) G. Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- (2008) Gopal Krishna et al. PHARMACOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now